Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BRIDGEWATER, N.J., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company marketing innovative diagnostic tools for colorectal cancer, today announced that data demonstrating the...
-
OMER, Israel, Jan. 16, 2017 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization...
-
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 12, 2017 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of...
-
OMER, Israel, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization...
-
BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...
-
BRIDGEWATER, N.J., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the appointment of Mark...
-
BRIDGEWATER, N.J., Dec. 20, 2016 (GLOBE NEWSWIRE) -- Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera™, a...
-
BURLINGTON, Mass., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration...
-
BURLINGTON, Mass., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, will provide a...
-
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of...